Decreased expression of p33ING1 mRNA in lymphoid malignancies

被引:0
|
作者
Ohmori, M
Nagai, M
Tasaka, T
Koeffler, HP
Riabowol, K
Takahara, J
机构
[1] Kagawa Med Univ, Dept Internal Med 1, Miki, Kagawa 7610793, Japan
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol,Cedars Sinai Res Inst, Los Angeles, CA 90024 USA
[3] Univ Calgary, Dept Med Biochem, Calgary, AB T2N 1N4, Canada
[4] Univ Calgary, So Alberta Canc Res Ctr, Calgary, AB T2N 1N4, Canada
关键词
p33ING1; p53; 13q34; lymphoma;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ING1 is a newly cloned putative tumor-suppressor gene, which is involved in the p53 signaling pathway. We found decreased expression of ING1 mRNA in 4 of 5 T-cell lines and 5 of 11 B-cell lines including two Burkitt lymphomas and two myelomas, These observations suggest that decreased ING1 expression might play an important role In the development or progression of some lymphoid tumors. Polymerase chain reaction-SSCP and sequencing analyses found neither paint mutations nor small deletions in the ING1 gene, suggesting that decreased expression is due to transcriptional or posttranscriptional mechanisms. Am. J. Hematol. 62:118-119, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:118 / 119
页数:2
相关论文
共 50 条
  • [31] p33ING1在胃癌中的表达及其临床意义
    朱博
    宋超
    王丹娜
    俞岚
    赵艳
    陶仪声
    蚌埠医学院学报, 2018, 43 (02) : 160 - 163+167
  • [32] Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas
    Shinoura, N
    Muramatsu, Y
    Nishimura, M
    Yoshida, Y
    Saito, A
    Yokoyama, T
    Furukawa, T
    Horii, A
    Hashimoto, M
    Asai, A
    Kirino, T
    Hamada, H
    CANCER RESEARCH, 1999, 59 (21) : 5521 - 5528
  • [33] 皮肤鳞状细胞癌组织中p33ING1蛋白的表达
    姚莹
    中国医药指南, 2014, 12 (07) : 58 - 59
  • [34] Inactivation of p33ING1 tumor suppressor affects the function of the cell cycle "checkpoints" and stability of the genome
    Turovets, NA
    Agapova, LS
    Kopnin, PB
    Tulina, NM
    Chumakov, PM
    Kopnin, BP
    RUSSIAN JOURNAL OF GENETICS, 2000, 36 (03) : 305 - 312
  • [35] TP53 and p33Ing1 are co-determinants of prognosis in colorectal cancer.
    Ahmed, IARM
    Nouman, GS
    Kelly, SB
    Bailey, N
    Anderson, JJ
    Angus, B
    Lunec, J
    GASTROENTEROLOGY, 2002, 122 (04) : A124 - A124
  • [36] The novel tumor suppressor p33ING1 is overexpressed but rarely mutated in human melanoma cell lines
    Campos, E
    Cheung, J
    Li, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 482 - 482
  • [37] 胃癌组织中p33ING1基因的表达及突变的检测
    丁厚中
    杨栋
    吴福荣
    李海
    冯坤
    郑斯杰
    倪灿荣
    于观贞
    中华医学杂志, 2003, (04) : 61 - 64
  • [38] P33ING1基因的生物学功能及研究进展
    倪灿荣
    临床与实验病理学杂志, 2002, (02) : 198 - 200
  • [39] 皮肤鳞状细胞癌组织中p33ING1蛋白的表达
    姚莹
    梁虹
    张启国
    张璃
    曾静
    医学临床研究, 2005, (09) : 1197 - 1199
  • [40] 宫颈癌组织中P33ING1、P53、Bcl-2检测
    王鲁文
    申霞
    王立新
    郑州大学学报(医学版), 2005, (04) : 661 - 663